Coined by Roederer and Tarnok , an optimized multicolor immunofluorescence panel (OMIP) refers to a thoroughly tested and validated set of antibodies and reagents that can be used together for the multicolor characterization or evaluation of a specific cell state or response. For example, OMIP-001 is optimized for evaluating the quality and phenotype of Ag-responsive human T cells ; OMIP-009 is optimized for characterizing the immunological response of human T cells .
Published in the journal Cytometry Part A (Wiley Online Library), the first group of OMIPs are designed for flow cytometry, but an OMIP can potentially be defined for image cytometry, fluorescence microscopy, and other polychromatic fluorescence-based methods. The development and publication of these OMIPs not only helps to alleviate the burden of panel development and optimization by providing the technical details and experimental conditions used to optimize each panel (details usually omitted in published research reports), but also creates an online repository for OMIPs so that all researchers can easily search and access the information. Moreover, their publication provides a process for peer review of optimized panel data, as well as a platform where researchers can get recognition and credit for the amount of work and effort it takes to develop an OMIP .
By definition, an OMIP publication includes all of the necessary information required for the execution of the panel of interest. The publication contains an overview of the purpose of the panel, a listing of antibody clones and fluorophore combinations, information on sample type, and similarities to any existing OMIPs; a representative figure shows experimental results, including the gating scheme. The supplemental material provides the developmental strategy, a detailed staining protocol, and technical information on antibody conjugate titration and panel optimization. The nomenclature used to identify each OMIP began with “OMIP-001” , and the numerical designation continues to increase as new OMIPs are peer-reviewed and then published in Cytometry Part A. To date, the majority of the OMIPs published have been developed for flow cytometry, which is likely due to the complexity of immunophenotyping studies performed using the platform.
An example of an OMIP that was developed for flow cytometry is OMIP-009, which was designed to study the human T cell immunological response to patient vaccination . The list of labeling reagents used for the study and the corresponding products from Thermo Fisher Scientific can be found in Table 1. The data acquired using the optimized conditions for this panel are shown in Figure 1 .
Figure 1. Example of immunophenotyping using OMIP-009. Data shown are from CMV1 donor cells stimulated with pp65 peptide pool (15-mers overlapping by 11). (A) Singlets are identified through the use of a forward scatter area (FSC-A) vs. forward scatter height (FSC-H) plot. Nonviable and CD3+ cells are excluded, allowing for the selection of the live CD3+ T cells only. A FSC-A vs. side scatter area (SSC-A) plot permits the additional removal of very low-scatter cells. The selected CD3+ T cell population is then further delineated into CD4+ and CD8+ T cells. (B) Gated on either CD4+ or CD8+ T cells, the percentage of responding cells for each cytokine is determined. (C) Using Boolean gating logic in the FlowJo analysis program, the ‘‘or’’ function is used to create a single gate of all cytokine-producing cells from a combination of existing cytokine gates, i.e., IFN-γ+ or IL-2+ or TNF+. Thus any cell that makes one or more cytokines is included in the gate. The total cytokine response (red) is then overlaid onto its respective CD4+ (top) or CD8+ (bottom) T cell lineage (gray) to identify the maturation and activation phenotype of the responding cells. Reprinted by permission from John Wiley & Sons Inc: Lamoreaux L, Koup RA, Roederer M (2012) OMIP-009: Characterization of antigen-specific human T-cells. Cytometry A 81:362–363.
|Reagents used for OMIP-009 ||Comparable Thermo Fisher Scientific products|
|CD3||SP342||APC-Cy 7||CD3||UCHT1||APC-Cy 7||100 µg||A15440|
|CD4||T4||ECD (PE–Texas-Red)||CD4||S3.5||PE–Texas Red||0.5 mL||MHCD0417|
|CD8||RPA-T8||Pacific Blue||CD8||3B5||Pacific Blue||500 µL||MHCD0828|
|CD45RA||L48||PE-Cy 7||CD45RA||HI100||PE-Cy 7||25 tests||A16358|
|CD28||CD28.2||PE-Cy 5||CD28||Not available|
|CCR7 (CD197)||150503||Alexa Fluor 680||CCR7 (CD197)||Not available|
|Dead cells||Not applicable||LIVE/DEAD Fixable Aqua Stain||Dead cells||Not applicable||LIVE/DEAD Fixable Aqua Stain||80 tests|
OMIP publications enable researchers to save a significant amount of time and money in the creation of their own panels. Even if the OMIP is not a perfect fit for a particular study, reviewing the strategy employed by other researchers in the development of a similar OMIP could prove invaluable to the design of the new panel. When developing a new panel for flow cytometry or other polychromatic fluorescence-based method, other considerations include:
There are several resources available to help you get started with your own panel optimization [5–11], including a short article published in BioProbes 71 called “Flow Cytometry Panel Design: The Basics” .
For Research Use Only. Not for use in diagnostic procedures.